Print Page | Contact Us | Sign In | Join ASFA
June 2020 Webinar - Sickle Cell Disease: Tips for Improving Outcomes
Tell a Friend About This EventTell a Friend

When: June 19, 2020
12:00 PM
Where: GoToWebinar
United States
Contact: ASFA Head Office

Online registration is closed.
« Go to Upcoming Event List  

Title: Sickle Cell Disease: Tips for Improving Outcomes
Date: Friday, June 19, 2020: World Sickle Cell Day
Time: 12:00pm - 1:00pm ET
Speaker: Julie Kanter, MD and Marisa Marques, MD

Dr. Julie Kanter is a lifespan hematologist specializing in sickle cell disease.  Dr. Kanter is the director of the adult sickle cell disease program and co-director of the comprehensive sickle cell research center.

Dr. Kanter is very committed to improving outcomes in sickle cell disease and ensuring those outcomes reach the affected individuals.  She works closely with national partners including the American Society of Hematology and the NIH on both advocacy and research.  Dr. Kanter works on the development of novel therapeutics in sickle cell disease with expertise in clinical trial endpoints and trial design as well as in areas of improving access to care.  Dr. Kanter and colleagues lead a large dissemination and implementation project to improve the use of TCD screening for stroke prevention in the United States. While in South Carolina, Dr. Kanter developed a statewide program (SC)2 for sickle cell disease and she plans to develop a similar model of access to care in Alabama. Dr. Kanter has authored and co-authored more than 50 articles, book chapters, and abstracts and hopes to train upcoming physicians and providers in sickle cell disease to expand the workforce for treating affected individuals.

Dr. Marques received her M.D. from the Federal University of Rio Grande do Sul in Brazil and trained in Internal Medicine at the same institution. She and her husband moved to the United States in 1986. She is a pathologist with subspecialties in Hematology and Transfusion Medicine/Blood Banking.  At UAB, she serves as the medical director of Transfusion Services and the Apheresis Collection Facility and a former director of the large therapeutic apheresis service.  She is very active in the Apheresis community, having been an ASFA Board member for 8 years and President from 2014-2015.

Learning Objectives:

  1. Recognize the systemic complications in sickle cell disease (JK)
  2. Identify the transfusion related complications in sickle cell disease (MM)
  3. Discuss how depletion exchange can be used for patients on chronic transfusion therapy (MM)
  4. Identify novel therapies in development for sickle cell disease (JK)

©2020 American Society for Apheresis (ASFA). All rights reserved.
American Society for Apheresis and the ASFA logo are registered service marks.